Puma Biotechnology Inc. (PBYI) Lifted to Hold at Zacks Investment Research
According to Zacks, "Puma, which focuses on the development and commercialization of innovative treatments that enhance cancer care, is a development-stage biotech company. Investor focus is on its progress with its breast cancer candidate, neratinib.
from Biotech News
0 Comments